| Laura Selby, DO | |
|
2500 Ne Neff Rd, Bend, OR 97701-6015 | |
| (541) 706-7715 | |
| (541) 706-7742 |
| Full Name | Laura Selby |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 2500 Ne Neff Rd, Bend, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902290877 | NPI | - | NPPES |
| 500749154 | Medicaid | OR | |
| DO208990 | Other | OR | OREGON LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | DO208990 (Oregon) | Primary |
| 207R00000X | Internal Medicine | PG183133 (Oregon) | Secondary |
| Entity Name | St Charles Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982621447 PECOS PAC ID: 3870402852 Enrollment ID: O20040112000045 |
News Archive
China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced preliminary unaudited financial results for the fourth quarter and full year fiscal 2010.
Just in case you hadn't noticed, no one has elected Grover Norquist to anything. Still, he looms as a major obstacle to Congress reaching a deficit-reduction agreement needed to raise the federal debt ceiling. … what's revealing about Norquist's passionate advocacy against taxes is that it virtually ignores the main causes of bigger government: Social Security and Medicare.
Kaplan EduNeering, a leading provider of compliance and knowledge management solutions, and the Drug Information Association (DIA), a global professional member association, announced a new strategic alliance to create online educational offerings for biotechnology, pharmaceutical, academic, and regulatory professionals around the world.
Senate Democratic leaders on Wednesday said that if a consensus cannot be reached with Republicans on a stop-gap spending measure for SCHIP, a spending provision for the program will be attached to an Iraq supplemental bill set to be discussed in late March or early April, CongressDaily reports.
CPEX Pharmaceuticals, Inc. today announced that the ongoing Phase 2a clinical trial of Nasulin™, the Company's intranasal insulin candidate, has now completed enrollment. The study was initiated in February of this year and randomized 94 subjects. Results are expected at the end of the first quarter or beginning of the second quarter of 2010.
› Verified 3 days ago
| Entity Name | St Charles Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023331303 PECOS PAC ID: 8729111513 Enrollment ID: O20100730000227 |
News Archive
China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced preliminary unaudited financial results for the fourth quarter and full year fiscal 2010.
Just in case you hadn't noticed, no one has elected Grover Norquist to anything. Still, he looms as a major obstacle to Congress reaching a deficit-reduction agreement needed to raise the federal debt ceiling. … what's revealing about Norquist's passionate advocacy against taxes is that it virtually ignores the main causes of bigger government: Social Security and Medicare.
Kaplan EduNeering, a leading provider of compliance and knowledge management solutions, and the Drug Information Association (DIA), a global professional member association, announced a new strategic alliance to create online educational offerings for biotechnology, pharmaceutical, academic, and regulatory professionals around the world.
Senate Democratic leaders on Wednesday said that if a consensus cannot be reached with Republicans on a stop-gap spending measure for SCHIP, a spending provision for the program will be attached to an Iraq supplemental bill set to be discussed in late March or early April, CongressDaily reports.
CPEX Pharmaceuticals, Inc. today announced that the ongoing Phase 2a clinical trial of Nasulin™, the Company's intranasal insulin candidate, has now completed enrollment. The study was initiated in February of this year and randomized 94 subjects. Results are expected at the end of the first quarter or beginning of the second quarter of 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Selby, DO Po Box 6095, Bend, OR 97708-6095 Ph: (541) 706-5922 | Laura Selby, DO 2500 Ne Neff Rd, Bend, OR 97701-6015 Ph: (541) 706-7715 |
News Archive
China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced preliminary unaudited financial results for the fourth quarter and full year fiscal 2010.
Just in case you hadn't noticed, no one has elected Grover Norquist to anything. Still, he looms as a major obstacle to Congress reaching a deficit-reduction agreement needed to raise the federal debt ceiling. … what's revealing about Norquist's passionate advocacy against taxes is that it virtually ignores the main causes of bigger government: Social Security and Medicare.
Kaplan EduNeering, a leading provider of compliance and knowledge management solutions, and the Drug Information Association (DIA), a global professional member association, announced a new strategic alliance to create online educational offerings for biotechnology, pharmaceutical, academic, and regulatory professionals around the world.
Senate Democratic leaders on Wednesday said that if a consensus cannot be reached with Republicans on a stop-gap spending measure for SCHIP, a spending provision for the program will be attached to an Iraq supplemental bill set to be discussed in late March or early April, CongressDaily reports.
CPEX Pharmaceuticals, Inc. today announced that the ongoing Phase 2a clinical trial of Nasulin™, the Company's intranasal insulin candidate, has now completed enrollment. The study was initiated in February of this year and randomized 94 subjects. Results are expected at the end of the first quarter or beginning of the second quarter of 2010.
› Verified 3 days ago
Alanna Mozena, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Ashley Marie Twyman, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 Fax: 541-706-6813 | |
Dr. Gilbert B. Lee, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1558 Sw Nancy Way, Bend, OR 97702 Phone: 541-312-8679 | |
Ms. Christine Marie Pierson, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2965 Ne Conners Ave, Ste 280, Bend, OR 97701 Phone: 541-323-4269 | |
Dr. Michael N Harris, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-2811 | |
Gordon Jeremy Juriansz, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-6892 | |
Dr. Ronald Daniel Rosen, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 918 Ne 5th St, Bend, OR 97701 Phone: 541-388-3804 Fax: 541-388-3856 |